 |
|
|
|
|
|
|
|
 |
Results for 'Vaccines to 2008' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
The Vaccines 2008
World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
|
April 2008 |
£2750 |
95 % |
Global Vaccines Market 2008-2023, The
|
August 2008 |
£1499 |
92 % |
China Vaccine & Database Package
|
December 2007 |
£3355 |
40.5 % |
Global Vaccine Market Forecast to 2012
|
October 2008 |
£1340 |
35 % |
World Market for Vaccines, The
|
November 2004 |
£2680 |
32.5 % |
Cancer Vaccines: Aim and Shoot
|
May 2008 |
£1635 |
29.05 % |
Global Vaccine Market Outlook (2007-2010)
|
June 2007 |
£1075 |
28.35 % |
Commercial and Pipeline Insight
Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead
|
July 2008 |
£7700 |
25.55 % |
Commercial and Pipeline Insight
Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead
|
July 2008 |
£7700 |
25.55 % |
GlaxoSmithKline Prospects to 2010
Pipeline, Products,Performance,Potential
|
February 2008 |
£595 |
24 % |
Biopharmaceutical Products in the US and European Markets
6th Edition
|
September 2007 |
£1000 |
19.5 % |
Booming Biotech Market in India
|
June 2008 |
£475 |
18.9 % |
Pipeline Insight: Nosocomial Vaccines
Minefield or Goldmine?
|
April 2008 |
£6000 |
17.85 % |
Bioject Medical Technologies Inc. Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£45 |
17.15 % |
Mexico Pharmaceuticals and Healthcare Report Q3 2008
|
July 2008 |
£425 |
16 % |
Stakeholder Opinions: Biologics in Infectious Diseases
Well Defined Target Populations Are Key to Commercial Success
|
March 2008 |
£2005 |
15.75 % |
Veterinary Health Markets
|
August 2007 |
£2280 |
15.4 % |
Stakeholder Opinions
Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies
|
July 2008 |
£3800 |
15.05 % |
Netherlands Pharmaceuticals and Healthcare Report Q4 2008
|
October 2008 |
£425 |
14 % |
Valuing Pharmaceutical Innovation
Pricing and Reimbursement for Innovative Therapies
|
July 2008 |
£1995 |
13.65 % |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
|
September 2004 |
£1045 |
13.3 % |
Bioject Medical Technologies Inc. Medical Equipment Company Share Analysis
|
September 2008 |
£380 |
12.25 % |
Global Cancer Treatment Forecast to 2012
|
August 2008 |
£535 |
11.9 % |
M&A trends in Pharma
|
October 2008 |
£6000 |
11.55 % |
Drug Development Opportunities In China
Regulation, Key Players And Initiatives For Domestic And International Markets
|
September 2007 |
£1495 |
11.2 % |
Commercial Insight: Select Herpes Viruses and Human Papilloma Virus
Non-Biologic Interventions for Oral and Genital Herpes, Cytomegalovirus Infection, Herpes Zoster and Genital Warts
|
August 2008 |
£7600 |
10.85 % |
Emerging Cancer Therapies
Markets and Business Opportunities
|
June 2002 |
£875 |
10.5 % |
Global Antivirals Market Analysis & Forecasts 2008-2023
|
September 2008 |
£1499 |
10.5 % |
Russia Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
10 % |
Brazil Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
10 % |
Pipeline Insight: Breast Cancer
Recent approvals increase pressure on pipeline candidates
|
April 2008 |
£6000 |
9.5 % |
Cancer Therapeutics
Market Insight and R&D Pipeline Analysis
|
August 2008 |
£1450 |
9.45 % |
Emerging Diabetes Drugs
Competitor Analysis
|
November 2008 |
£410 |
9 % |
Pfizer - Market Outlook for a Global Leader, 2008-2013
|
August 2008 |
£2999 |
8.75 % |
Emerging Pharmaceutical Markets Globally
|
April 2008 |
£1005 |
8.75 % |
Sanofi-aventis
Pipeline, Products,Performance,Potential
|
September 2007 |
£595 |
8.5 % |
Gene Therapy
Technologies, Markets and Companies
|
September 2008 |
£1435 |
8.5 % |
Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
|
May 2008 |
£6000 |
8.4 % |
AstraZeneca Plc
PharmaVitae Profile
|
July 2008 |
£3010 |
8.05 % |
World Allergy Market 2006-2011, The
The Rx-OTC Rush
|
October 2006 |
£1499 |
7.7 % |
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007
|
April 2008 |
£1065 |
7.5 % |
United States Diabetes Care Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies
|
April 2008 |
£1015 |
7.35 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£535 |
6.65 % |
Chinese Markets for Drug Delivery Systems
|
May 2004 |
£1985 |
6.65 % |
Cancer Therapeutics Markets
|
May 2008 |
£2280 |
6.65 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£535 |
6.65 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£1075 |
6.65 % |
South Africa Pharmaceuticals and Healthcare Report Q3 2008
|
June 2008 |
£425 |
6.65 % |
The U.S. Market for EMR Technologies
|
January 2007 |
£2680 |
6.3 % |
Angiogenesis Modulators
|
January 2008 |
£1880 |
5.6 % |
AstraZeneca
Pharmaceuticals, Company Profile and Healthcare
|
June 2008 |
£595 |
5.25 % |
Respironics Medical Device Company Intelligence Report
Medical Devices, Company Profile and Healthcare
|
November 2005 |
£295 |
5.25 % |
The Pharmaceutical Market: Estonia
|
December 2007 |
£595 |
5.25 % |
United States in Vitro Diagnostics Industry Report
Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits
|
May 2008 |
£2010 |
4.9 % |
'Big Pharma' Turns to Biologics for Growth to 2010
Financial and strategic segmentation of the 'Big Pharma' sector by drug technology
|
May 2006 |
£4000 |
4.9 % |
Medical Nanotechnology Markets
|
September 2008 |
£2280 |
4.2 % |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
|
January 2008 |
£1499 |
4.2 % |
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008
|
May 2007 |
£285 |
3.5 % |
F. Hoffmann-La Roche Ltd. Medical Equipment Company Share Analysis
|
September 2008 |
£380 |
3.5 % |
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009
|
June 2008 |
£285 |
3.5 % |
In-Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
2.45 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
2.45 % |
|
|
|
|
